The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
ganirelix acetate · Powder
5 marketed package NDCs · 5 active manufacturers
Most dispensed: 250 ug/.5mL · Injection · #1 syringe, glass/carton / 1 ml in 1 syringe, glass · 250 ug/.5mL · Injection, Solution · #1 blister pack/carton / 1 syringe, glass in 1 blister pack / 1 ml in 1 syringe, glass · 250 ug/.5mL · Injection, Solution · #1 blister pack/carton / 1 syringe in 1 blister pack / .5 ml in 1 syringe · 250 ug/.5mL · Injection, Solution · #1 blister pack/carton / 1 syringe, glass in 1 blister pack / .5 ml in 1 syringe, glass
Same drug class
Other molecules FDA puts in Gonadotropin Releasing Hormone Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Ganirelix acetate in shortage right now?
- No. FDA does not currently list Ganirelix acetate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ganirelix acetate?
- 15 companies have marketed Ganirelix acetate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.